recognizable_JJ stages_NNS of_IN lymphopoiesis_NN ._.
DNTT_NN is_VBZ also_RB expressed_VBN on_IN their_PRP$ malignant_JJ counterparts_NNS ,_, making_VBG it_PRP an_DT important_JJ marker_NN in_IN distinguishing_VBG lymphoblastic_JJ leukemia_NN from_IN other_JJ hematologic_JJ neoplasms_NNS =_JJ -_: =[_NN 16_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Instead_RB of_IN considering_VBG only_RB the_DT best_JJS rated_VBN visualization_NN ,_, we_PRP can_MD examine_VB several_JJ top_NN ranked_VBD projections_NNS to_TO find_VB genessSGCA_NN CD83_NN IGF2_NN FCGBP_NN c_NN la_DT s_NN s_NN E_NN W_NN S_NN B_NN L_NN N_NN B_NN R_NN M_NN S_NN 81210_CD DNMT2_NN GALGT_NN -LRB-_-LRB- a_NN -RRB-_-RRB- -LRB-_-LRB- b_NN -RRB-_-RRB- Figu_NN
